Melbourne biotech Starpharma signed an exclusive worldwide oncology licence with Genentech, a Roche Group company, locking in US$5.5 million upfront and success payments worth up to US$564 million plus tiered royalties on DEP dendrimer-drug conjugates.
Fortescue will expand autonomous rail operations in the Pilbara after months of union talks, pairing battery-electric locomotives with remote Hive control as the AWU pursues site-level agreements.
Whitehaven Coal secured extra ARTC train paths into Newcastle before a 72-hour Hunter Valley rail shutdown, moving Gunnedah Basin tonnes early so September export targets survive track renewal across 135 sites.
Origin Energy is leaving published east-coast business gas tariffs unchanged while AEMO's winter review shows Iona and southern storage fields drawn down by gas-powered generation, keeping contract renewals tense for factories and retailers.